The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 20, 2018

Filed:

Feb. 28, 2017
Applicant:

Astrazeneca Ab, Sodertalje, SE;

Inventors:

Robert Hugh Bradbury, Macclesfield, GB;

David Buttar, Macclesfield, GB;

Christopher De Savi, Waltham, MA (US);

Craig Samuel Donald, Macclesfield, GB;

Richard Albert Norman, Macclesfield, GB;

Alfred Arthur Rabow, Macclesfield, GB;

Gordon Stuart Currie, Macclesfield, GB;

Heather Redfearn, Macclesfield, GB;

Nadim Akhtar, Macclesfield, GB;

Helen Elizabeth Williams, Macclesfield, GB;

Matthew Osborne, Macclesfield, GB;

Neda Yavari, Macclesfield, GB;

Assignee:

AstraZeneca AB, Sodertalje, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 31/519 (2006.01); C07D 487/04 (2006.01); C07D 471/04 (2006.01); A61K 45/06 (2006.01); C07C 57/145 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); C07C 57/145 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07B 2200/07 (2013.01); C07B 2200/13 (2013.01);
Abstract

The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein Rto Rhave any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.


Find Patent Forward Citations

Loading…